-
-
-
-
-
-
-
Biogen gets European approval for postpartum depression treatment
-
-
-
-
-
-
-
Supernus gets regulatory clearance for Sage acquisition
-
-
-
-
-
-
-
Supernus Announces Fourth Quarter and Full Year 2022 Financial Results
-
-
-
-
-
-
-
Supernus Announces First Quarter 2022 Financial Results
-
-
-
-
-
-
-
Supernus Pharma (SUPN) Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals (ADMS) Tender Offer
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/11: (PTGX) (ADMS) (FLXN) Higher; (HYLN) (LUV) (NET) Lower (more...)
-
-
-
-
-
-
-
Supernus Announces Fourth Quarter and Full Year 2020 Financial Results
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

